Work Here?
Unlearn.AI creates digital twins of patients using artificial intelligence to simulate health outcomes and predict changes in a patient's health over time. These virtual replicas allow healthcare providers to make more informed treatment decisions and can be used by pharmaceutical companies in clinical trials to simulate control groups, which may expedite drug development and approval processes. Unlike traditional methods, Unlearn.AI's approach reduces the need for actual human control groups, saving time and resources. The company operates on a service or subscription model, charging clients for access to its AI-powered technology. Unlearn.AI stands out in the digital health market by offering a unique solution that enhances decision-making in patient care and drug development.
Company Stage
Series C
Employees
51-200
Industries
AI & Machine Learning, Biotechnology, Healthcare
Total Funding
$134.8M
Headquarters
N/A
Founded
2017
Find jobs on Simplify and start your career today